does the oral glp 1 work GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care FAQ | InVita Health &

The SUSTAIN-6 trial, which evaluated semaglutide in patients with type 2 diabetes at high cardiovascular risk, identified a statistically significant increase in diabetic retinopathy complications in the semaglutide group compared to placebo

Average body weight reductions ranged from approximately 15% to 21% depending on dose at 72 weeks - again from the studied FDA-approved formulation under controlled conditions

K., Samreen, N., Zhou, Y., Chen, J., Brandt, K., Ehman, R., et al

Extensive dermal melanocytosis that affects the ventral as well as dorsal trunk, persists, and progresses in extent over time can represent a sign of a lysosomal storage disease (eg, Hurler syndrome or GM1 gangliosidosis)